Trulieve Cannabis (TRLV) Reiterated at Overweight by Cantor Fitzgerald on 'Solid Foundation'

Cantor Fitzgerald analyst Gabie Ingoglia reiterated an Overweight rating and $15.00 price target on Trulieve Cannabis (NYSE: TRLV).

The analyst commented, "TRLV’s solid foundation remains a key driver of our Overweight rating & was reinforced during our NDR. Its competitive edge lies in understanding its customers, an advantage we believe will persist regardless of the regulatory or companyspecific growth outlook. This foundation supports our thesis even without these catalysts, but the growing number of upside levers makes the current entry point particularly attractive."

For an analyst ratings summary and ratings history on Trulieve Cannabis click here. For more ratings news on Trulieve Cannabis click here.

Shares of Trulieve Cannabis closed at $8.36 yesterday.

You May Also Be Interested In

• Bumble Inc. (BMBL) PT Lowered to $3.20 at Citi
• BIO-key posts 13% revenue gain and narrower Q2 net loss
• Diginex reports 77% revenue rise but $31M net loss in FY2026